American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic potential of NTRK3 inhibition in desmoplastic small round cell tumor
    Journal Article

    Ogura, K.; Somwar, R.; Hmeljak, J.; Magnan, H.; Benayed, R.; Momeni Boroujeni, A.; Bowman, A. S.; Mattar, M. S.; Khodos, I.; de Stanchina, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti-PD-(L)1 therapy
    Journal Article

    Hellmann, M. D.; Jänne, P. A.; Opyrchal, M.; Hafez, N.; Raez, L. E.; Gabrilovich, D. I.; Wang, F.; Trepel, J. B.; Lee, M. J.; Yuno, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pleiotropic mechanisms drive endocrine resistance in the three-dimensional bone microenvironment
    Journal Article

    Dhimolea, E.; de Matos Simoes, R.; Kansara, D.; Weng, X.; Sharma, S.; Awate, P.; Liu, Z.; Gao, D.; Mitsiades, N.; Schwab, J. H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • The genetic evolution of treatment-resistant cutaneous, acral, and uveal melanomas
    Journal Article

    Makohon-Moore, A. P.; Lipson, E. J.; Hooper, J. E.; Zucker, A.; Hong, J.; Bielski, C. M.; Hayashi, A.; Tokheim, C.; Baez, P.; Kappagantula, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Characterization and clinical outcomes of DNA mismatch repair-deficient small bowel adenocarcinoma
    Journal Article

    Latham, A.; Shia, J.; Patel, Z.; Reidy-Lagunes, D. L.; Segal, N. H.; Yaeger, R.; Ganesh, K.; Connell, L.; Kemeny, N. E.; Kelsen, D. P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Expression of T-cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to nivolumab in metastatic clear cell renal cell carcinoma
    Journal Article

    Ficial, M.; Jegede, O. A.; Sant'Angelo, M.; Hou, Y.; Flaifel, A.; Pignon, J. C.; Braun, D. A.; Wind-Rotolo, M.; Sticco-Ivins, M. A.; Catalano, P. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A performance comparison of commonly used assays to detect RET fusions
    Journal Article

    Yang, S. R.; Aypar, U.; Rosen, E. Y.; Mata, D. A.; Benayed, R.; Mullaney, K.; Jayakumaran, G.; Zhang, Y.; Frosina, D.; Drilon, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Somatic epigenetic silencing of RIPK3 inactivates necroptosis and contributes to chemoresistance in malignant mesothelioma
    Journal Article

    Tan, Y.; Sementino, E.; Cheung, M.; Peri, S.; Menges, C. W.; Kukuyan, A. M.; Zhang, T.; Khazak, V.; Fox, L. A.; Ross, E. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase I study of the efficacy and safety of ramucirumab in combination with osimertinib in advanced T790M-positive EGFR-mutant non-small cell lung cancer
    Journal Article

    Yu, H. A.; Paz-Ares, L. G.; Yang, J. C. H.; Lee, K. H.; Garrido, P.; Park, K.; Kim, J. H.; Lee, D. H.; Mao, H.; Wijayawardana, S. R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: